• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国儿童失明的病因研究——IRIS® 注册研究(智能视觉研究)。

Causes of Childhood Blindness in the United States Using the IRIS® Registry (Intelligent Research in Sight).

机构信息

Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; Department of Ophthalmology, Hanyang University School of Medicine, Seoul, Republic of Korea.

Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; Ophthalmology and Eye Care Services, VA Palo Alto Health Care System, Palo Alto, California.

出版信息

Ophthalmology. 2023 Sep;130(9):907-913. doi: 10.1016/j.ophtha.2023.04.004. Epub 2023 Apr 8.

DOI:10.1016/j.ophtha.2023.04.004
PMID:37037315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10524509/
Abstract

PURPOSE

To investigate causes of childhood blindness in the United States using the IRIS® Registry (Intelligent Research in Sight).

DESIGN

Cross-sectional study.

PARTICIPANTS

Patients ≤ 18 years of age with visual acuity (VA) 20/200 or worse in their better-seeing eye in the IRIS Registry during 2018.

METHODS

Causes of blindness were classified by anatomic site and specific diagnoses.

MAIN OUTCOME MEASURES

Percentages of causes of blindness.

RESULTS

Of 81 164 children with 2018 VA data in the IRIS Registry, 961 (1.18%) had VA 20/200 or worse in their better-seeing eye. Leading causes of blindness were retinopathy of prematurity (ROP) in 301 patients (31.3%), nystagmus in 78 patients (8.1%), and cataract in 64 patients (6.7%). The retina was the leading anatomic site (47.7%) followed by optic nerve (11.6%) and lens (10.0%). A total of 52.4% of patients had treatable causes of blindness.

CONCLUSIONS

This analysis offers a unique cross-sectional view of childhood blindness in the United States using a clinical data registry. More than one-half of blind patients had a treatable cause of blindness.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

摘要

目的

利用智能研究视觉(IRIS®)登记处调查美国儿童失明的原因。

设计

横断面研究。

参与者

在 2018 年的 IRIS 登记处中,视力(VA)≥20/200 的≤18 岁患者,其较好眼的 VA 更差。

方法

通过解剖部位和特定诊断对失明原因进行分类。

主要观察指标

失明原因的百分比。

结果

在 81164 名具有 2018 年 VA 数据的儿童中,961 名(1.18%)其较好眼的 VA 为 20/200 或更差。失明的主要原因是早产儿视网膜病变(ROP)301 例(31.3%)、眼球震颤 78 例(8.1%)和白内障 64 例(6.7%)。视网膜是主要的解剖部位(47.7%),其次是视神经(11.6%)和晶状体(10.0%)。共有 52.4%的患者有可治疗的失明原因。

结论

本分析利用临床数据登记处提供了美国儿童失明的独特横断面视图。超过一半的盲童有可治疗的失明原因。

金融披露

本文结尾的脚注和披露中可能有专有或商业披露。

相似文献

1
Causes of Childhood Blindness in the United States Using the IRIS® Registry (Intelligent Research in Sight).美国儿童失明的病因研究——IRIS® 注册研究(智能视觉研究)。
Ophthalmology. 2023 Sep;130(9):907-913. doi: 10.1016/j.ophtha.2023.04.004. Epub 2023 Apr 8.
2
United States Population Disparities in Ophthalmic Care: Blindness and Visual Impairment in the IRIS® Registry (Intelligent Research in Sight).美国眼科护理中的人口差异:IRIS® 注册研究中的失明和视力损害(智能视觉研究)。
Ophthalmology. 2023 Nov;130(11):1121-1137. doi: 10.1016/j.ophtha.2023.06.011. Epub 2023 Jun 17.
3
An update on progress and the changing epidemiology of causes of childhood blindness worldwide.全球儿童失明病因的进展及流行病学变化最新情况
J AAPOS. 2012 Dec;16(6):501-7. doi: 10.1016/j.jaapos.2012.09.004.
4
Cystoid Macular Edema after Cataract Surgery in the United States: IRIS® Registry (Intelligent Research in Sight) Analysis.美国白内障手术后的囊样黄斑水肿:IRIS® 注册研究(有远见的智能研究)分析。
Ophthalmology. 2023 Oct;130(10):1005-1014. doi: 10.1016/j.ophtha.2023.06.001. Epub 2023 Jun 9.
5
Visual Acuity Outcomes and Complications after Intraocular Lens Exchange: An IRIS® Registry (Intelligent Research in Sight) Analysis.人工晶状体置换术后的视力结果和并发症:IRIS® 注册研究(智能视觉研究)分析。
Ophthalmology. 2024 Apr;131(4):403-411. doi: 10.1016/j.ophtha.2023.10.021. Epub 2023 Oct 18.
6
Corneal Opacity in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Study.美国的角膜混浊:美国眼科学会IRIS®注册研究(视力智能研究)
Ophthalmology. 2025 Jan;132(1):52-61. doi: 10.1016/j.ophtha.2024.07.005. Epub 2024 Jul 8.
7
[The causes of childhood blindness and visual impairment in Poland].[波兰儿童失明及视力损伤的原因]
Klin Oczna. 2001;103(2-3):117-20.
8
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.北京城乡地区失明和视力损伤的病因:北京眼病研究
Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2.
9
Prevalence and causes of blindness in children in Vietnam.越南儿童盲症的患病率及病因。
Ophthalmology. 2012 Feb;119(2):355-61. doi: 10.1016/j.ophtha.2011.07.037. Epub 2011 Oct 27.
10
Causes of childhood low vision and blindness in New Zealand.新西兰儿童低视力和盲的病因。
Clin Exp Ophthalmol. 2019 Mar;47(2):165-170. doi: 10.1111/ceo.13443. Epub 2019 Jan 4.

引用本文的文献

1
Elevated Ocular and Visual Disorder Risk in Developmental Disabilities: Insights from Cross-Sectional Study and Mendelian Randomization Analysis.发育障碍中眼部和视觉障碍风险升高:横断面研究和孟德尔随机化分析的见解
J Autism Dev Disord. 2025 Jul 31. doi: 10.1007/s10803-025-06989-4.
2
Nitro-Oleic acid protects from neovascularization, oxidative stress, gliosis and neurodegeneration in oxygen-induced retinopathy.硝基油酸可预防氧诱导性视网膜病变中的新生血管形成、氧化应激、胶质细胞增生和神经退行性变。
Redox Biol. 2025 Jun;83:103634. doi: 10.1016/j.redox.2025.103634. Epub 2025 Apr 12.
3
Translating time: Challenges, progress, and future directions.翻译时间:挑战、进展与未来方向。
Brain Res Bull. 2025 Feb;221:111212. doi: 10.1016/j.brainresbull.2025.111212. Epub 2025 Jan 15.
4
Retinal blood flow association with age and weight in infants at risk for retinopathy of prematurity.早产儿视网膜病变高危婴儿的视网膜血流与年龄和体重的关系。
Sci Rep. 2024 Jun 4;14(1):12790. doi: 10.1038/s41598-024-63534-6.
5
Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity.补充氧气在减少早产儿 2 期早产儿视网膜病变激光或玻璃体内贝伐单抗治疗需求中的疗效。
BMC Ophthalmol. 2024 May 24;24(1):220. doi: 10.1186/s12886-024-03483-w.
6
Association of Speckle-Based Blood Flow Measurements and Fluorescein Angiography in Infants with Retinopathy of Prematurity.基于散斑的血流测量与早产儿视网膜病变婴儿荧光素血管造影的相关性
Ophthalmol Sci. 2023 Dec 29;4(4):100463. doi: 10.1016/j.xops.2023.100463. eCollection 2024 Jul-Aug.
7
Multi-registry analysis of patients with multiple sclerosis and neuromyelitis optica to improve capture of demographic data and compare visual outcomes.多中心研究多发性硬化症和视神经脊髓炎患者,以改进人口统计学数据的采集并比较视觉结局。
Mult Scler Relat Disord. 2024 Apr;84:105499. doi: 10.1016/j.msard.2024.105499. Epub 2024 Feb 11.
8
Using Natural Language Processing to Identify Different Lens Pathology in Electronic Health Records.利用自然语言处理技术在电子健康记录中识别不同的晶状体病变。
Am J Ophthalmol. 2024 Jun;262:153-160. doi: 10.1016/j.ajo.2024.01.030. Epub 2024 Feb 1.
9
Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysis.通过计算药物-基因关联分析鉴定早产儿视网膜病变治疗策略的新型候选化合物。
Front Pediatr. 2023 Jul 10;11:1151239. doi: 10.3389/fped.2023.1151239. eCollection 2023.

本文引用的文献

1
American Academy of Ophthalmology Intelligent Research in Sight (IRIS®) Registry and the IRIS Registry Analytic Center Consortium.美国眼科学会视力智能研究(IRIS®)注册库及IRIS注册库分析中心联盟。
Ophthalmol Sci. 2022 Jan 8;2(1):100112. doi: 10.1016/j.xops.2022.100112. eCollection 2022 Mar.
2
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.玻璃体内注射阿柏西普与激光光凝治疗早产儿视网膜病变的疗效比较:FIREFLEYE 随机临床试验。
JAMA. 2022 Jul 26;328(4):348-359. doi: 10.1001/jama.2022.10564.
3
Retinopathy of Prematurity Treatment Trends from 2003 to 2020 in the United States.美国早产儿视网膜病变治疗趋势:2003 年至 2020 年。
Ophthalmology. 2022 Oct;129(10):1216-1218. doi: 10.1016/j.ophtha.2022.06.008. Epub 2022 Jun 15.
4
Referral patterns for infantile cataracts in two regions of the United States.美国两个地区婴儿白内障的转诊模式。
J AAPOS. 2022 Feb;26(1):6.e1-6.e5. doi: 10.1016/j.jaapos.2021.09.006. Epub 2021 Dec 29.
5
Temporal trends in the epidemiology of childhood severe visual impairment and blindness in the UK.英国儿童严重视力损害和失明流行病学的时间趋势。
Br J Ophthalmol. 2023 May;107(5):717-724. doi: 10.1136/bjophthalmol-2021-320119. Epub 2021 Dec 23.
6
Higher Visual Function Deficits in Children With Cerebral Visual Impairment and Good Visual Acuity.视力正常的脑性视觉障碍儿童存在更高的视觉功能缺陷。
Front Hum Neurosci. 2021 Nov 16;15:711873. doi: 10.3389/fnhum.2021.711873. eCollection 2021.
7
Motion Processing Deficits in Children With Cerebral Visual Impairment and Good Visual Acuity.运动处理缺陷在具有良好视力的脑性视觉障碍儿童中。
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):12. doi: 10.1167/iovs.62.14.12.
8
Trends in Retinopathy of Prematurity Screening and Treatment: 2008-2018.早产儿视网膜病变筛查与治疗的趋势:2008 - 2018年
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-039966. Epub 2021 May 11.
9
The U.S. National Trend for Retinopathy of Prematurity.美国早产儿视网膜病变的全国趋势。
Am J Perinatol. 2022 Oct;29(14):1569-1576. doi: 10.1055/s-0041-1723830. Epub 2021 Feb 16.
10
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.